drugset / Trial / NCT04972045
Bioavailability of Curcumin Capsules in Healthy Adult Subjects
Phase 1
Completed
12 enrolled
The Affiliated Hospital of Qingdao University
Chenland Nutritionals Inc. · collab
RandomizedCrossoverOpen-labelPrevention
Summary
A single-center, open-label, randomized, two-period, crossover study design of pharmacokinetics and bioavailability in healthy adult male and female subjects under fasting conditions.
Timeline
- Start
- 2021-04-09
- Primary completion
- 2021-04-23
- Completion
- 2021-06-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcumin | Small molecule | 1600 mg | — |
Indications
No indication recorded.